Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Neurobiology of Aging

Volumn 19, Issue 1, 1998, Pages 33-36

  Markesbery, W R ^a   Lovell, M A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Brain; Four hydroxynonenal; Lipid peroxidation; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; POLYUNSATURATED FATTY ACID;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN; BRAIN REGION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NERVE CELL DEGENERATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SUBICULUM;

AGED; AGED, 80 AND OVER; ALDEHYDES; ALZHEIMER DISEASE; AMYGDALA; BRAIN CHEMISTRY; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HIPPOCAMPUS; HUMANS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS;

EID: 0031980065     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00009-8     Document Type: Article

References (37)

1. Blanc E. M., Kelly J. F., Mark R. J., Waeg G., Mattson M. P. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors Possible action on G alpha (g/11) . J. Neurochem. 69:1997;570-580.
2. Bruce-Keller, A. D.; Li, Y.-J.; Lovell, M. A.; Kraemer, P. J.; Gary, D. S.; Brown, R. R.; Markesbery, W. R.; Mattson, M. P. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. In press; 1998.
3. Ehmann W. D., Markesbery W. R., Alauddin M., Hossain T. I. M. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
4. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
5. Francis P. T., Cross A. J., Bowen D. M. Neurotransmitters and neuropeptides. Terry R. D., Katzman R., Bick K. L. Alzheimer disease. 1994;247-261 Raven Press, Ltd, New York.
6. Geula C., Mesulam M. M. Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. Terry R. D., Katzman R., Beck K. L. Alzheimer disease. 1994;263-291 Raven Press, Ltd, New York.
7. Good P. F., Perl D. P., Bierer L. M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease A laser microprobe (LAMMA) study . Ann. Neurol. 31:1992;286-292.
8. Good P. F., Werner P., Hsu A., Olanow C. W., Perl D. P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
9. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M. A., Markesbery W. R., Butterfield D. A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
10. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide Role of the lipid peroxidation product 4-hydroxynonenal . J. Neurochem. 69:1997;273-284.
11. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
12. Kruman I., Bruce-Keller A. J., Bredesen D., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
13. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;263-275.
14. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
15. Lovell M. A., Ehmann W. D., Mattson M. P., Markesbery W. R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
16. Lovell, M. A.; Markesbery, W. R. Four-hydroxynonenal selectively impairs choline acetyltransferase in cell cultures. Submitted, 1998.
17. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
18. Mark R. J., Pang Z., Geddes J. W., Uchida K., Mattson M. P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons Involvement of membrane lipid peroxidation . J. Neurosci. 17:1997;1046-1054.
19. Markesbery W. R. The oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease . Neurology. 34:1984;939-944.
21. Mecocci P., MacGarvey U., Beal M. F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
22. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
23. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O., Graham D. G., Montine T. J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150:1997;437-443.
24. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., Graham D. G. 4-Hydroxy-2-nonenal is cytotoxic and cross links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148:1996;89-94.
25. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., Markesbery W. R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:1998;81-83.
26. Samudralwar D. L., Diprete C. C., Ni B. F., Ehmann W. D., Markesbery W. R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
27. Sayre, L. M.; Zelasko, D. A.; Harris, P. L. R.; Perry, G.; Salomon, R. G.; Smith, M. A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 2092-2097; 1997.
28. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., Markesbery W. R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
29. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
30. Smith M. A., Sayre L., Monnier V., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
31. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
32. Svennerholm L., Gottfries C. G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
33. Thompson C. M., Markesbery W. R., Ehmann W. D., Mao Y.-X., Vance D. E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-8.
34. Uchida K., Stadtman E. R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-e-phosphate dehydrogenase. J. Biol. Chem. 268:1993;6388-6393.
35. Wenstrup, D.; Ehmann, W.; Markesbery, W. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res. 533:135-131; 1990.
36. Yan S. D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y. S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S. H., Stern D. Glycated tau protein in Alzheimer disease A mechanism for induction of oxidant stress . Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
37. Yoshino K., Matsuura T., Sano M., Saito S.-I., Tomita I. Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem. Pharm. Bull. 34:1986;1694-1700.